Non-muscle-invasive bladder cancer is labor intensive and costly to manage. Owing to long-term survival rates and life-long monitoring and treatment, it is the most expensive cancer to manage in ...

Photocure ASA (OSE: PHO), the Bladder Cancer Company, and Artera, a leading precision medicine company, announce launch of a joint research initiative. The collaboration encompasses Photocure's blue ...

Five hospitals in England and Wales have switched to urine test, rather than invasive hospital procedure ...

If a diagnosis of TCC of the bladder is suspected, urinary cytology followed by white-light cystoscopy of the bladder is performed. Although white-light cystoscopy is reliable in the detection of ...

A simple urine test can more than halve the number of cystoscopies necessary to follow up high-risk bladder cancer patients, new research has found. Cystoscopies involve inserting a flexible probe ...

Patients with early-stage bladder cancer are often able to maintain their usual routines. Some may experience urinary ...

June 4, 2010 — The US Food and Drug Administration (FDA) has approved hexaminolevulinate HCl (Cysview; GE Healthcare, under license from Photocure ASA) for the detection of non-muscle-invasive ...

In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...

A new urine test could spare bladder cancer survivors from a painful follow-up procedure needed to ensure their cancer hasn't come back, researchers report. People who've gotten surgery for high-risk ...

The presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood ...

The presence of blood cells in urine is a sign of bladder cancer. Because aspirin blocks platelets from forming harmful blood ...